Details of the Drug

General Information of Drug (ID: DMOWCHQ)

Drug Name

CBL-514

Indication

Disease Entry	ICD 11	Status	REF
Subcutaneous fat disorder	EF02	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04897412) A 2-Stage Adaptive Design, Phase 2 Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal and Thigh Subcutaneous Fat (Stage 2). U.S.National Institutes of Health.